7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          We investigated risk of coronary heart disease and heart failure in phenotypes of obstructive airway disease.

          Methods

          Among 91 692 participants in the Copenhagen General Population Study, 42 058 individuals were classified with no respiratory disease, and 11 988 individuals had different phenotypes of obstructive airways disease: asthma with early onset or late-onset, chronic obstructive pulmonary disease (COPD) with forced expiratory volume in one second (FEV 1) above or below 50% of predicted value (%p) or asthma-COPD overlap (ACO).

          Results

          During a mean follow-up of 5.7 years we registered 3584 admissions for coronary heart disease and 1590 admissions for heart failure. Multivariable Cox regression analyses of time to first admission were used with a two-sided p value of 0.05 as significance level. Compared with no respiratory disease the highest risks of coronary heart disease and heart failure were observed in ACO with late-onset asthma and FEV 1 <50% p, HR=2.2 (95% CI 1.6 to 3.0), and HR=2.9 (95% CI 2.0 to 4.3), respectively. In COPD with FEV 1 above 50% p the HRs were 1.3 (95% CI 1.2 to 1.5) for coronary heart disease and 1.9 (95% CI 1.6 to 2.3) for heart failure. Asthma associated with increased risks of coronary heart disease and heart failure, however, in asthma without allergy the HR was 1.1 (95% CI 0.7 to 1.6) for coronary heart disease while individuals with allergy had an HR of 1.4 (95% CI 1.1 to 1.6).

          Conclusions

          Risks of coronary heart disease and heart failure were increased in asthma, COPD and ACO. In asthma, the risk of coronary heart disease depended on presence of allergy. We suggest that cardiovascular risk factors should be assessed systematically in individuals with obstructive airway disease with the potential to facilitate targeted treatments.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          The development of allergic inflammation.

          Allergic disorders, such as anaphylaxis, hay fever, eczema and asthma, now afflict roughly 25% of people in the developed world. In allergic subjects, persistent or repetitive exposure to allergens, which typically are intrinsically innocuous substances common in the environment, results in chronic allergic inflammation. This in turn produces long-term changes in the structure of the affected organs and substantial abnormalities in their function. It is therefore important to understand the characteristics and consequences of acute and chronic allergic inflammation, and in particular to explore how mast cells can contribute to several features of this maladaptive pattern of immunological reactivity.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study

            Objective The majority of cardiovascular diagnoses in the Danish National Patient Registry (DNPR) remain to be validated despite extensive use in epidemiological research. We therefore examined the positive predictive value (PPV) of cardiovascular diagnoses in the DNPR. Design Population-based validation study. Setting 1 university hospital and 2 regional hospitals in the Central Denmark Region, 2010–2012. Participants For each cardiovascular diagnosis, up to 100 patients from participating hospitals were randomly sampled during the study period using the DNPR. Main outcome measure Using medical record review as the reference standard, we examined the PPV for cardiovascular diagnoses in the DNPR, coded according to the International Classification of Diseases, 10th Revision. Results A total of 2153 medical records (97% of the total sample) were available for review. The PPVs ranged from 64% to 100%, with a mean PPV of 88%. The PPVs were ≥90% for first-time myocardial infarction, stent thrombosis, stable angina pectoris, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, takotsubo cardiomyopathy, arterial hypertension, atrial fibrillation or flutter, cardiac arrest, mitral valve regurgitation or stenosis, aortic valve regurgitation or stenosis, pericarditis, hypercholesterolaemia, aortic dissection, aortic aneurysm/dilation and arterial claudication. The PPVs were between 80% and 90% for recurrent myocardial infarction, first-time unstable angina pectoris, pulmonary hypertension, bradycardia, ventricular tachycardia/fibrillation, endocarditis, cardiac tumours, first-time venous thromboembolism and between 70% and 80% for first-time and recurrent admission due to heart failure, first-time dilated cardiomyopathy, restrictive cardiomyopathy and recurrent venous thromboembolism. The PPV for first-time myocarditis was 64%. The PPVs were consistent within age, sex, calendar year and hospital categories. Conclusions The validity of cardiovascular diagnoses in the DNPR is overall high and sufficient for use in research since 2010.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The Asthma-COPD Overlap Syndrome.

              Although in textbooks asthma and chronic obstructive pulmonary disease (COPD) are viewed as distinct disorders, there is increasing awareness that many patients have features of both. This article reviews the asthma-COPD overlap syndrome.
                Bookmark

                Author and article information

                Journal
                BMJ Open Respir Res
                BMJ Open Respir Res
                bmjresp
                bmjopenrespres
                BMJ Open Respiratory Research
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                2052-4439
                2020
                3 February 2020
                : 7
                : 1
                : e000470
                Affiliations
                [1 ] departmentRespiratory Section, Department of Internal Medicine , Herlev and Gentofte Hospital, Copenhagen University Hospital , Hellerup, Denmark
                [2 ] departmentThe Copenhagen General Population Study, Herlev and Gentofte Hospital , Copenhagen University Hospital , Herlev, Denmark
                [3 ] departmentThe Copenhagen City Heart Study, Frederiksberg Hospital , Copenhagen University Hospital , Frederiksberg, Denmark
                [4 ] departmentDivision of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Sciences Centre , University of Manchester , Manchester, United Kingdom
                [5 ] departmentDepartment of Clinical Biochemistry, Herlev and Gentofte Hospital , Copenhagen University Hospital , Herlev, Denmark
                [6 ] departmentFaculty of Health and Medical Sciences , University of Copenhagen , Copenhagen, Denmark
                [7 ] departmentMedical department O, Herlev and Gentofte Hospital , Copenhagen University Hospital , Herlev, Denmark
                [8 ] departmentSection of Epidemiology, Department of Public Health, Faculty of Health Sciences , University of Copenhagen , Copenhagen, Denmark
                Author notes
                [Correspondence to ] Dr Peter Lange; peter.lange@ 123456sund.ku.dk
                Author information
                http://orcid.org/0000-0001-5892-7659
                Article
                bmjresp-2019-000470
                10.1136/bmjresp-2019-000470
                7011896
                33371008
                c3dc38fc-1794-4fc9-99d0-d3b3ba7cb44f
                © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

                This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 29 July 2019
                : 22 October 2019
                : 10 December 2019
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100002066, GlaxoSmithKline foundation;
                Award ID: unrestricted grant: EPI 115882 – EUPharmaLocal
                Funded by: FundRef http://dx.doi.org/10.13039/501100003491, Herlev Hospital;
                Funded by: Capital Region of Copenhagen;
                Funded by: Danish Lung Foundation;
                Funded by: FundRef http://dx.doi.org/10.13039/100008397, Velux Fonden;
                Categories
                Respiratory Epidemiology
                1506
                2228
                Custom metadata
                unlocked

                clinical epidemiology,copd epidemiology
                clinical epidemiology, copd epidemiology

                Comments

                Comment on this article